CAU
INVA icon

Caxton Associates (UK)’s Innoviva INVA Stock Holding History

Caxton Associates (UK)’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-85,029
Closed -$1.7M – 893
2025
Q4 		$1.7M Buy
85,029
+56,996
+203% +$1.11M 0.03% 242
2025
Q3 		$512K Buy
28,033
+9,310
+50% +$182K 0.01% 455
2025
Q2 		$376K Sell
18,723
-33,123
-64% -$637K 0.01% 491
2025
Q1 		$940K Buy
+51,846
New +$929K 0.03% 339

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caxton Associates (UK)'s INVA Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Innoviva (INVA) in Q1 2026, closing a stake of 85,029 shares — an estimated $1.7M sold.

Caxton Associates (UK) first reported a position in INVA in Q1 2025 and held it in 4 quarters. The position peaked at $1.7M in Q4 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Innoviva position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 85,029 Innoviva shares in Q1 2026, an estimated $1.7M.
  • Caxton Associates (UK) first reported a position in Innoviva in Q1 2025 and held it in 4 quarters.
  • Caxton Associates (UK)'s Innoviva position peaked at $1.7M in Q4 2025.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.